🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Indacaterol acetate - Medicines in Ireland

8 authorised products containing Indacaterol acetate, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 8 authorised medicines
MedicineActive substanceLicence holderStatus
Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsules
EU/1/20/1439/005-008
 Indacaterol acetate, Mometasone furoate Novartis Europharm Limited —
Atectura Breezhaler 125 micrograms/260 micrograms inhalation powder, hard capsules
EU/1/20/1439/009-012
 Indacaterol acetate, Mometasone furoate Novartis Europharm Limited —
Atectura Breezhaler 125 micrograms/62.5 micrograms inhalation powder, hard capsules
EU/1/20/1439/001-004
 Indacaterol acetate, Mometasone furoate Novartis Europharm Limited —
Bemrist Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsules
EU/1/20/1441/005-008
 Indacaterol acetate, Indacaterol, Mometasone furoate Novartis Europharm Limited —
Bemrist Breezhaler 125 micrograms/260 micrograms inhalation powder, hard capsules
EU/1/20/1441/009-012
 Indacaterol acetate, Indacaterol, Mometasone furoate Novartis Europharm Limited —
Bemrist Breezhaler 125 micrograms/62.5 micrograms inhalation powder, hard capsules
EU/1/20/1441/001-004
 Indacaterol acetate, Indacaterol, Mometasone furoate Novartis Europharm Limited —
Enerzair Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules
EU/1/20/1438/001-005
 Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate Novartis Europharm Limited —
Zimbus Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules
EU/1/20/1440/001-05
 Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate Novartis Europharm Limited —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.